http://www.cnr.it/ontology/cnr/individuo/prodotto/ID246840
High Density Lipoprotein Cholesterol in Coronary Artery Disease: When Higher Means Later (Articolo in rivista)
- Type
- Label
- High Density Lipoprotein Cholesterol in Coronary Artery Disease: When Higher Means Later (Articolo in rivista) (literal)
- Anno
- 2013-01-01T00:00:00+01:00 (literal)
- Alternative label
Francesco Sbrana, Mariarita Puntoni, Federico Bigazzi, Patrizia Landi, Tiziana Sampietro, Giuseppe Rossi, Daniele Rovai (2013)
High Density Lipoprotein Cholesterol in Coronary Artery Disease: When Higher Means Later
in Journal of atherosclerosis and thrombosis
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Francesco Sbrana, Mariarita Puntoni, Federico Bigazzi, Patrizia Landi, Tiziana Sampietro, Giuseppe Rossi, Daniele Rovai (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
- https://www.jstage.jst.go.jp/article/jat/20/1/20_13201/_article (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Fondazione Toscana Gabriele Monasterio, Pisa, Italy. CNR, Clinical Physiology Institute, Pisa, Italy. (literal)
- Titolo
- High Density Lipoprotein Cholesterol in Coronary Artery Disease: When Higher Means Later (literal)
- Abstract
- Aim: Although high-density lipoprotein cholesterol (HDL-C) levels are inversely associated with cardiovascular risk, patients with elevated HDL-C also develop coronary artery disease (CAD) and cardiac events. We aimed to draw the clinical profile of CAD patients with elevated HDL-C and to assess the prognostic impact of elevated HDL-C. Methods: We prospectively examined 2322 patients (age 67±10 years, 79% male) with chronic CAD, defined by >50% coronary stenosis and/or previous myocardial infarction. Results: HDL-C levels were low (<35 mg/dL) in 736 patients (32%), normal (35-60 mg/dL) in 1464 (63%), and high (>60 mg/dL) in 122 (5%). Patients with elevated HDL-C were less frequently male (p<0.0001), smokers (p<0.0001), diabetic (p<0.0001), and obese (p<0.0015) than those with low or normal HDL-C, but were 3 and 5 years older, respectively (p<0.0001). During follow-up (median, 46 months) 143 patients died from cardiac causes and 80 developed a non-fatal infarction. Cardiac event-free survival was lower in patients with low compared to normal HDL-C (p<0.0001), but was not significantly different from that of patients with elevated HDL-C. The prognostic impact of low HDL-C was independent of age, sex, diabetes, LV function, extent of coronary stenoses, low density lipoprotein cholesterol, triglycerides, complete blood count, thyroid and renal function (p<0.0001). Conversely, the prognostic impact of elevated HDL-C disappeared (p>0.10) after adjustment for age. Conclusion: Patients with elevated HDL-C develop CAD and cardiac events as do those with low or normal HDL, but at a more advanced age. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di